Poster

Comparability Study Of An Ion Exchange Monolith And Affinity Resin For The Purification Of AAV8

Source: Sartorius

By Janja Merkelj Koren, Rok Žigon, Andrej Mihevc, Marko Šnajder, Maja Leskovec, and Aleš Štrancar

GettyImages-1938554519-lab-computer-research-discovery

The main objective of every downstream process (DSP) for adeno-associated virus (AAV) production is to achieve high recovery, purity, and potency. The capture step for AAV purification is typically either affinity or cation exchange chromatography, both of which concentrate the product and remove impurities. Following the capture, the eluate is generally further processed to enrich for full capsids and carry out further purification. CIMmultus® QA, a monolith-based anion exchange chromatography column, is widely used for the enrichment and polishing of full AAV capsids1.

Since the polishing step relies on only small differences in charge of the AAV capsids, any process-induced heterogeneity or charge modulation of the capture eluate will diminish the separation efficiency and affect the step’s robustness. Affinity elution samples are reported to contain additional impurities2 which influence the performance and duration of subsequent DSP steps. A side-by-side comparison was performed using a CIMmultus® SO3—1 mL (2 µm) column and a commercially available affinity resin that binds several AAV serotypes. Both columns were evaluated for process and step recoveries, impurity reduction, product capacity, and processing time. The results shown are based on two parallel experiments for each capture approach.

access the Poster!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Pharmaceutical Online? Subscribe today.

Subscribe to Pharmaceutical Online X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Pharmaceutical Online